Global Mantle Cell Lymphoma Treatment Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 12-Jan-2021
No. of pages: 92
Inquire Before Buying

Mantle Cell Lymphoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Mantle Cell Lymphoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Acalabrutinib

- JCAR-017

- JNJ-64052781

- Acalisib

- IGN-002

- IMGN-529

- AFM-11

- Others

Segment by Application

- Hospital

- Clinic

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Astex Pharmaceuticals, Inc.

- Bayer AG

- Bristol-Myers Squibb Company

- Celgene Corporation

- Cellular Biomedicine Group, Inc.

- Eisai

- EpiZyme, Inc.

- Fate Therapeutics, Inc.

- Genentech, Inc.

- Celgene Corporation

- Cellular Biomedicine Group, Inc.

- Hutchison MediPharma Limited

- ImmunoGen, Inc.

Global Mantle Cell Lymphoma Treatment Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mantle Cell Lymphoma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Acalabrutinib
1.2.3 JCAR-017
1.2.4 JNJ-64052781
1.2.5 Acalisib
1.2.6 IGN-002
1.2.7 IMGN-529
1.2.8 AFM-11
1.2.9 Others
1.3 Market by Application
1.3.1 Global Mantle Cell Lymphoma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Mantle Cell Lymphoma Treatment Market Perspective (2016-2027)
2.2 Mantle Cell Lymphoma Treatment Growth Trends by Regions
2.2.1 Mantle Cell Lymphoma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Mantle Cell Lymphoma Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Mantle Cell Lymphoma Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Mantle Cell Lymphoma Treatment Industry Dynamic
2.3.1 Mantle Cell Lymphoma Treatment Market Trends
2.3.2 Mantle Cell Lymphoma Treatment Market Drivers
2.3.3 Mantle Cell Lymphoma Treatment Market Challenges
2.3.4 Mantle Cell Lymphoma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mantle Cell Lymphoma Treatment Players by Revenue
3.1.1 Global Top Mantle Cell Lymphoma Treatment Players by Revenue (2016-2021)
3.1.2 Global Mantle Cell Lymphoma Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Mantle Cell Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Mantle Cell Lymphoma Treatment Revenue
3.4 Global Mantle Cell Lymphoma Treatment Market Concentration Ratio
3.4.1 Global Mantle Cell Lymphoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mantle Cell Lymphoma Treatment Revenue in 2020
3.5 Mantle Cell Lymphoma Treatment Key Players Head office and Area Served
3.6 Key Players Mantle Cell Lymphoma Treatment Product Solution and Service
3.7 Date of Enter into Mantle Cell Lymphoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Mantle Cell Lymphoma Treatment Breakdown Data by Type
4.1 Global Mantle Cell Lymphoma Treatment Historic Market Size by Type (2016-2021)
4.2 Global Mantle Cell Lymphoma Treatment Forecasted Market Size by Type (2022-2027)
5 Mantle Cell Lymphoma Treatment Breakdown Data by Application
5.1 Global Mantle Cell Lymphoma Treatment Historic Market Size by Application (2016-2021)
5.2 Global Mantle Cell Lymphoma Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Mantle Cell Lymphoma Treatment Market Size (2016-2027)
6.2 North America Mantle Cell Lymphoma Treatment Market Size by Type
6.2.1 North America Mantle Cell Lymphoma Treatment Market Size by Type (2016-2021)
6.2.2 North America Mantle Cell Lymphoma Treatment Market Size by Type (2022-2027)
6.2.3 North America Mantle Cell Lymphoma Treatment Market Size by Type (2016-2027)
6.3 North America Mantle Cell Lymphoma Treatment Market Size by Application
6.3.1 North America Mantle Cell Lymphoma Treatment Market Size by Application (2016-2021)
6.3.2 North America Mantle Cell Lymphoma Treatment Market Size by Application (2022-2027)
6.3.3 North America Mantle Cell Lymphoma Treatment Market Size by Application (2016-2027)
6.4 North America Mantle Cell Lymphoma Treatment Market Size by Country
6.4.1 North America Mantle Cell Lymphoma Treatment Market Size by Country (2016-2021)
6.4.2 North America Mantle Cell Lymphoma Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Mantle Cell Lymphoma Treatment Market Size (2016-2027)
7.2 Europe Mantle Cell Lymphoma Treatment Market Size by Type
7.2.1 Europe Mantle Cell Lymphoma Treatment Market Size by Type (2016-2021)
7.2.2 Europe Mantle Cell Lymphoma Treatment Market Size by Type (2022-2027)
7.2.3 Europe Mantle Cell Lymphoma Treatment Market Size by Type (2016-2027)
7.3 Europe Mantle Cell Lymphoma Treatment Market Size by Application
7.3.1 Europe Mantle Cell Lymphoma Treatment Market Size by Application (2016-2021)
7.3.2 Europe Mantle Cell Lymphoma Treatment Market Size by Application (2022-2027)
7.3.3 Europe Mantle Cell Lymphoma Treatment Market Size by Application (2016-2027)
7.4 Europe Mantle Cell Lymphoma Treatment Market Size by Country
7.4.1 Europe Mantle Cell Lymphoma Treatment Market Size by Country (2016-2021)
7.4.2 Europe Mantle Cell Lymphoma Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Mantle Cell Lymphoma Treatment Market Size (2016-2027)
8.2 Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Type
8.2.1 Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Application
8.3.1 Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Region
8.4.1 Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Mantle Cell Lymphoma Treatment Market Size (2016-2027)
9.2 Latin America Mantle Cell Lymphoma Treatment Market Size by Type
9.2.1 Latin America Mantle Cell Lymphoma Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Mantle Cell Lymphoma Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Mantle Cell Lymphoma Treatment Market Size by Type (2016-2027)
9.3 Latin America Mantle Cell Lymphoma Treatment Market Size by Application
9.3.1 Latin America Mantle Cell Lymphoma Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Mantle Cell Lymphoma Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Mantle Cell Lymphoma Treatment Market Size by Application (2016-2027)
9.4 Latin America Mantle Cell Lymphoma Treatment Market Size by Country
9.4.1 Latin America Mantle Cell Lymphoma Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Mantle Cell Lymphoma Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mantle Cell Lymphoma Treatment Market Size (2016-2027)
10.2 Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Type
10.2.1 Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Application
10.3.1 Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Country
10.4.1 Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Astex Pharmaceuticals, Inc.
11.1.1 Astex Pharmaceuticals, Inc. Company Details
11.1.2 Astex Pharmaceuticals, Inc. Business Overview
11.1.3 Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Introduction
11.1.4 Astex Pharmaceuticals, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2016-2021)
11.1.5 Astex Pharmaceuticals, Inc. Recent Development
11.2 Bayer AG
11.2.1 Bayer AG Company Details
11.2.2 Bayer AG Business Overview
11.2.3 Bayer AG Mantle Cell Lymphoma Treatment Introduction
11.2.4 Bayer AG Revenue in Mantle Cell Lymphoma Treatment Business (2016-2021)
11.2.5 Bayer AG Recent Development
11.3 Bristol-Myers Squibb Company
11.3.1 Bristol-Myers Squibb Company Company Details
11.3.2 Bristol-Myers Squibb Company Business Overview
11.3.3 Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Introduction
11.3.4 Bristol-Myers Squibb Company Revenue in Mantle Cell Lymphoma Treatment Business (2016-2021)
11.3.5 Bristol-Myers Squibb Company Recent Development
11.4 Celgene Corporation
11.4.1 Celgene Corporation Company Details
11.4.2 Celgene Corporation Business Overview
11.4.3 Celgene Corporation Mantle Cell Lymphoma Treatment Introduction
11.4.4 Celgene Corporation Revenue in Mantle Cell Lymphoma Treatment Business (2016-2021)
11.4.5 Celgene Corporation Recent Development
11.5 Cellular Biomedicine Group, Inc.
11.5.1 Cellular Biomedicine Group, Inc. Company Details
11.5.2 Cellular Biomedicine Group, Inc. Business Overview
11.5.3 Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Introduction
11.5.4 Cellular Biomedicine Group, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2016-2021)
11.5.5 Cellular Biomedicine Group, Inc. Recent Development
11.6 Eisai
11.6.1 Eisai Company Details
11.6.2 Eisai Business Overview
11.6.3 Eisai Mantle Cell Lymphoma Treatment Introduction
11.6.4 Eisai Revenue in Mantle Cell Lymphoma Treatment Business (2016-2021)
11.6.5 Eisai Recent Development
11.7 EpiZyme, Inc.
11.7.1 EpiZyme, Inc. Company Details
11.7.2 EpiZyme, Inc. Business Overview
11.7.3 EpiZyme, Inc. Mantle Cell Lymphoma Treatment Introduction
11.7.4 EpiZyme, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2016-2021)
11.7.5 EpiZyme, Inc. Recent Development
11.8 Fate Therapeutics, Inc.
11.8.1 Fate Therapeutics, Inc. Company Details
11.8.2 Fate Therapeutics, Inc. Business Overview
11.8.3 Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Introduction
11.8.4 Fate Therapeutics, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2016-2021)
11.8.5 Fate Therapeutics, Inc. Recent Development
11.9 Genentech, Inc.
11.9.1 Genentech, Inc. Company Details
11.9.2 Genentech, Inc. Business Overview
11.9.3 Genentech, Inc. Mantle Cell Lymphoma Treatment Introduction
11.9.4 Genentech, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2016-2021)
11.9.5 Genentech, Inc. Recent Development
11.10 Gilead Sciences, Inc.
11.10.1 Gilead Sciences, Inc. Company Details
11.10.2 Gilead Sciences, Inc. Business Overview
11.10.3 Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Introduction
11.10.4 Gilead Sciences, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2016-2021)
11.10.5 Gilead Sciences, Inc. Recent Development
11.11 GlaxoSmithKline Plc
11.11.1 GlaxoSmithKline Plc Company Details
11.11.2 GlaxoSmithKline Plc Business Overview
11.11.3 GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Introduction
11.11.4 GlaxoSmithKline Plc Revenue in Mantle Cell Lymphoma Treatment Business (2016-2021)
11.11.5 GlaxoSmithKline Plc Recent Development
11.12 Hutchison MediPharma Limited
11.12.1 Hutchison MediPharma Limited Company Details
11.12.2 Hutchison MediPharma Limited Business Overview
11.12.3 Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Introduction
11.12.4 Hutchison MediPharma Limited Revenue in Mantle Cell Lymphoma Treatment Business (2016-2021)
11.12.5 Hutchison MediPharma Limited Recent Development
11.13 ImmunoGen, Inc.
11.13.1 ImmunoGen, Inc. Company Details
11.13.2 ImmunoGen, Inc. Business Overview
11.13.3 ImmunoGen, Inc. Mantle Cell Lymphoma Treatment Introduction
11.13.4 ImmunoGen, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2016-2021)
11.13.5 ImmunoGen, Inc. Recent Development
11.14 Immunomedics, Inc.
11.14.1 Immunomedics, Inc. Company Details
11.14.2 Immunomedics, Inc. Business Overview
11.14.3 Immunomedics, Inc. Mantle Cell Lymphoma Treatment Introduction
11.14.4 Immunomedics, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2016-2021)
11.14.5 Immunomedics, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Mantle Cell Lymphoma Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Acalabrutinib
Table 3. Key Players of JCAR-017
Table 4. Key Players of JNJ-64052781
Table 5. Key Players of Acalisib
Table 6. Key Players of IGN-002
Table 7. Key Players of IMGN-529
Table 8. Key Players of AFM-11
Table 9. Key Players of Others
Table 10. Global Mantle Cell Lymphoma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Mantle Cell Lymphoma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Mantle Cell Lymphoma Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Mantle Cell Lymphoma Treatment Market Share by Regions (2016-2021)
Table 14. Global Mantle Cell Lymphoma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Mantle Cell Lymphoma Treatment Market Share by Regions (2022-2027)
Table 16. Mantle Cell Lymphoma Treatment Market Trends
Table 17. Mantle Cell Lymphoma Treatment Market Drivers
Table 18. Mantle Cell Lymphoma Treatment Market Challenges
Table 19. Mantle Cell Lymphoma Treatment Market Restraints
Table 20. Global Mantle Cell Lymphoma Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Mantle Cell Lymphoma Treatment Market Share by Players (2016-2021)
Table 22. Global Top Mantle Cell Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mantle Cell Lymphoma Treatment as of 2020)
Table 23. Ranking of Global Top Mantle Cell Lymphoma Treatment Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Mantle Cell Lymphoma Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Mantle Cell Lymphoma Treatment Product Solution and Service
Table 27. Date of Enter into Mantle Cell Lymphoma Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Mantle Cell Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Mantle Cell Lymphoma Treatment Revenue Market Share by Type (2016-2021)
Table 31. Global Mantle Cell Lymphoma Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Mantle Cell Lymphoma Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Mantle Cell Lymphoma Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Mantle Cell Lymphoma Treatment Revenue Market Share by Application (2016-2021)
Table 35. Global Mantle Cell Lymphoma Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Mantle Cell Lymphoma Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Mantle Cell Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Mantle Cell Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Mantle Cell Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Mantle Cell Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Mantle Cell Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Mantle Cell Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Mantle Cell Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Mantle Cell Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Mantle Cell Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Mantle Cell Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Mantle Cell Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Mantle Cell Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Mantle Cell Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Mantle Cell Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Mantle Cell Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Mantle Cell Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Mantle Cell Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Mantle Cell Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 67. Astex Pharmaceuticals, Inc. Company Details
Table 68. Astex Pharmaceuticals, Inc. Business Overview
Table 69. Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Product
Table 70. Astex Pharmaceuticals, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 71. Astex Pharmaceuticals, Inc. Recent Development
Table 72. Bayer AG Company Details
Table 73. Bayer AG Business Overview
Table 74. Bayer AG Mantle Cell Lymphoma Treatment Product
Table 75. Bayer AG Revenue in Mantle Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 76. Bayer AG Recent Development
Table 77. Bristol-Myers Squibb Company Company Details
Table 78. Bristol-Myers Squibb Company Business Overview
Table 79. Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Product
Table 80. Bristol-Myers Squibb Company Revenue in Mantle Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 81. Bristol-Myers Squibb Company Recent Development
Table 82. Celgene Corporation Company Details
Table 83. Celgene Corporation Business Overview
Table 84. Celgene Corporation Mantle Cell Lymphoma Treatment Product
Table 85. Celgene Corporation Revenue in Mantle Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 86. Celgene Corporation Recent Development
Table 87. Cellular Biomedicine Group, Inc. Company Details
Table 88. Cellular Biomedicine Group, Inc. Business Overview
Table 89. Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Product
Table 90. Cellular Biomedicine Group, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 91. Cellular Biomedicine Group, Inc. Recent Development
Table 92. Eisai Company Details
Table 93. Eisai Business Overview
Table 94. Eisai Mantle Cell Lymphoma Treatment Product
Table 95. Eisai Revenue in Mantle Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 96. Eisai Recent Development
Table 97. EpiZyme, Inc. Company Details
Table 98. EpiZyme, Inc. Business Overview
Table 99. EpiZyme, Inc. Mantle Cell Lymphoma Treatment Product
Table 100. EpiZyme, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 101. EpiZyme, Inc. Recent Development
Table 102. Fate Therapeutics, Inc. Company Details
Table 103. Fate Therapeutics, Inc. Business Overview
Table 104. Fate Therapeutics, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 105. Fate Therapeutics, Inc. Recent Development
Table 106. Genentech, Inc. Company Details
Table 107. Genentech, Inc. Business Overview
Table 108. Genentech, Inc. Mantle Cell Lymphoma Treatment Product
Table 109. Genentech, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 110. Genentech, Inc. Recent Development
Table 111. Gilead Sciences, Inc. Company Details
Table 112. Gilead Sciences, Inc. Business Overview
Table 113. Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Product
Table 114. Gilead Sciences, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 115. Gilead Sciences, Inc. Recent Development
Table 116. GlaxoSmithKline Plc Company Details
Table 117. GlaxoSmithKline Plc Business Overview
Table 118. GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Product
Table 119. GlaxoSmithKline Plc Revenue in Mantle Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 120. GlaxoSmithKline Plc Recent Development
Table 121. Hutchison MediPharma Limited Company Details
Table 122. Hutchison MediPharma Limited Business Overview
Table 123. Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Product
Table 124. Hutchison MediPharma Limited Revenue in Mantle Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 125. Hutchison MediPharma Limited Recent Development
Table 126. ImmunoGen, Inc. Company Details
Table 127. ImmunoGen, Inc. Business Overview
Table 128. ImmunoGen, Inc. Mantle Cell Lymphoma Treatment Product
Table 129. ImmunoGen, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 130. ImmunoGen, Inc. Recent Development
Table 131. Immunomedics, Inc. Company Details
Table 132. Immunomedics, Inc. Business Overview
Table 133. Immunomedics, Inc. Mantle Cell Lymphoma Treatment Product
Table 134. Immunomedics, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 135. Immunomedics, Inc. Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mantle Cell Lymphoma Treatment Market Share by Type: 2020 VS 2027
Figure 2. Acalabrutinib Features
Figure 3. JCAR-017 Features
Figure 4. JNJ-64052781 Features
Figure 5. Acalisib Features
Figure 6. IGN-002 Features
Figure 7. IMGN-529 Features
Figure 8. AFM-11 Features
Figure 9. Others Features
Figure 10. Global Mantle Cell Lymphoma Treatment Market Share by Application: 2020 VS 2027
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Others Case Studies
Figure 14. Mantle Cell Lymphoma Treatment Report Years Considered
Figure 15. Global Mantle Cell Lymphoma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Mantle Cell Lymphoma Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Mantle Cell Lymphoma Treatment Market Share by Regions: 2020 VS 2027
Figure 18. Global Mantle Cell Lymphoma Treatment Market Share by Regions (2022-2027)
Figure 19. Global Mantle Cell Lymphoma Treatment Market Share by Players in 2020
Figure 20. Global Top Mantle Cell Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mantle Cell Lymphoma Treatment as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Mantle Cell Lymphoma Treatment Revenue in 2020
Figure 22. Global Mantle Cell Lymphoma Treatment Revenue Market Share by Type (2016-2021)
Figure 23. Global Mantle Cell Lymphoma Treatment Revenue Market Share by Type (2022-2027)
Figure 24. North America Mantle Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Mantle Cell Lymphoma Treatment Market Share by Type (2016-2027)
Figure 26. North America Mantle Cell Lymphoma Treatment Market Share by Application (2016-2027)
Figure 27. North America Mantle Cell Lymphoma Treatment Market Share by Country (2016-2027)
Figure 28. United States Mantle Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Mantle Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Mantle Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Mantle Cell Lymphoma Treatment Market Share by Type (2016-2027)
Figure 32. Europe Mantle Cell Lymphoma Treatment Market Share by Application (2016-2027)
Figure 33. Europe Mantle Cell Lymphoma Treatment Market Share by Country (2016-2027)
Figure 34. Germany Mantle Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Mantle Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Mantle Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Mantle Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Mantle Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Mantle Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Mantle Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Mantle Cell Lymphoma Treatment Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Mantle Cell Lymphoma Treatment Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Mantle Cell Lymphoma Treatment Market Share by Region (2016-2027)
Figure 44. China Mantle Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Mantle Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Mantle Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Mantle Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Mantle Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Mantle Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Mantle Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Mantle Cell Lymphoma Treatment Market Share by Type (2016-2027)
Figure 52. Latin America Mantle Cell Lymphoma Treatment Market Share by Application (2016-2027)
Figure 53. Latin America Mantle Cell Lymphoma Treatment Market Share by Country (2016-2027)
Figure 54. Mexico Mantle Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Mantle Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Mantle Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Mantle Cell Lymphoma Treatment Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Mantle Cell Lymphoma Treatment Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Mantle Cell Lymphoma Treatment Market Share by Country (2016-2027)
Figure 60. Turkey Mantle Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Mantle Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Mantle Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Astex Pharmaceuticals, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2016-2021)
Figure 64. Bayer AG Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2016-2021)
Figure 65. Bristol-Myers Squibb Company Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2016-2021)
Figure 66. Celgene Corporation Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2016-2021)
Figure 67. Cellular Biomedicine Group, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2016-2021)
Figure 68. Eisai Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2016-2021)
Figure 69. EpiZyme, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2016-2021)
Figure 70. Fate Therapeutics, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2016-2021)
Figure 71. Genentech, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2016-2021)
Figure 72. Gilead Sciences, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2016-2021)
Figure 73. GlaxoSmithKline Plc Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2016-2021)
Figure 74. Hutchison MediPharma Limited Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2016-2021)
Figure 75. ImmunoGen, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2016-2021)
Figure 76. Immunomedics, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
  • Global Radiology Treatment Equipment Market Research Report 2021
    Published: 26-Jan-2021        Price: US 2900 Onwards        Pages: 91
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - External Beam Radiotherapy Equipment - Internal Beam Radiotherapy Equipment - Systemic Radiotherapy Equipme......
  • Global Emission Computed Tomography System Market Research Report 2021
    Published: 26-Jan-2021        Price: US 2900 Onwards        Pages: 93
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - 2S Spiral Scan CT - 16S Spiral Scan CT - 64S Spiral Scan CT - 128S Spiral Scan CT - 256S Spir......
  • Global Craniomaxillofacial Implants Market Research Report 2021
    Published: 26-Jan-2021        Price: US 2900 Onwards        Pages: 94
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Titanium and Alloys - Polymers/Biomaterials - Calcium Phosphate Ceramics Segment by Applicat......
  • Global Medical Stapler Market Research Report 2021
    Published: 26-Jan-2021        Price: US 2900 Onwards        Pages: 121
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Skin Stapler - Alimentary Canal Circular Stapler - Rectum Stapler - Blood Vessel Stapler - Ot......
  • Global Dental Restorative Materials Market Research Report 2021
    Published: 26-Jan-2021        Price: US 2900 Onwards        Pages: 121
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Dental Amalgams - Dental Cements - Dental Ceramics - Dental Liners Segment by Applica......
  • Global Veterinary Blood Analyser Market Research Report 2021
    Published: 26-Jan-2021        Price: US 2900 Onwards        Pages: 118
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Table Top Analyzers - Point of Care Analyzers Segment by Application - Research Institutes......
  • Global Medical Ceramic Ball Head Market Research Report 2021
    Published: 26-Jan-2021        Price: US 2900 Onwards        Pages: 95
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Sterilized Package - Non-sterilized Package Segment by Application - Hip Surface Replacement......
  • Global Fundus Imaging System Market Research Report 2021
    Published: 26-Jan-2021        Price: US 2900 Onwards        Pages: 118
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Low-end Fundus Imaging System - Middle-end Fundus Imaging System - High-end Fundus Imaging System ......
  • Global Ophthalmic Operating Microscope Market Research Report 2021
    Published: 26-Jan-2021        Price: US 2900 Onwards        Pages: 99
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Inside Light Source Microscope - Outside Light Source Microscope Segment by Application - Ho......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs